Middletown Life

Author: Fresenius Medical Care Holdings, Inc.

Fresenius Medical Care delivers 27% earnings growth in 2025 and reaches upper end of its financial outlook; margin within 2025 mid-term target band

February 24, 2026
Fresenius Medical Care accelerates the second tranche of its EUR 1 billion share buyback program with around EUR 415 million repurchase planned

January 9, 2026
Fresenius Medical Care appoints Charles Hugh-Jones as Global Chief Medical Officer and member of the Management Board

December 10, 2025
Fresenius Medical Care further accelerates organic revenue development and achieves an inflection in earnings growth, delivering 28% operating income growth in the third quarter of 2025

November 4, 2025
Fresenius Medical Care highlights real-world advances in hemodiafiltration and AI at ASN Kidney Week 2025

November 1, 2025